123 related articles for article (PubMed ID: 38458405)
21. Polymer nanomedicines based on micelle-forming amphiphilic or water-soluble polymer-doxorubicin conjugates: Comparative study of in vitro and in vivo properties related to the polymer carrier structure, composition, and hydrodynamic properties.
Braunová A; Chytil P; Laga R; Šírová M; Machová D; Parnica J; Říhová B; Janoušková O; Etrych T
J Control Release; 2020 May; 321():718-733. PubMed ID: 32142741
[TBL] [Abstract][Full Text] [Related]
22. Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect.
Kovár M; Strohalm J; Etrych T; Ulbrich K; Ríhová B
Bioconjug Chem; 2002; 13(2):206-15. PubMed ID: 11906257
[TBL] [Abstract][Full Text] [Related]
23. Novel star HPMA-based polymer conjugates for passive targeting to solid tumors.
Etrych T; Strohalm J; Chytil P; Říhová B; Ulbrich K
J Drug Target; 2011 Dec; 19(10):874-89. PubMed ID: 21978286
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of linear versus star-like polymer anti-cancer nanomedicines in mouse models.
Kostka L; Kotrchová L; Randárová E; Ferreira CA; Malátová I; Lee HJ; Olson AP; Engle JW; Kovář M; Cai W; Šírová M; Etrych T
J Control Release; 2023 Jan; 353():549-562. PubMed ID: 36470330
[TBL] [Abstract][Full Text] [Related]
25. Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacy.
Quan LD; Purdue PE; Liu XM; Boska MD; Lele SM; Thiele GM; Mikuls TR; Dou H; Goldring SR; Wang D
Arthritis Res Ther; 2010; 12(5):R170. PubMed ID: 20836843
[TBL] [Abstract][Full Text] [Related]
26. The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel.
Šírová M; Strohalm J; Chytil P; Lidický O; Tomala J; Říhová B; Etrych T
J Control Release; 2017 Jan; 246():1-11. PubMed ID: 27940304
[TBL] [Abstract][Full Text] [Related]
27. Polymer micelles with hydrazone-ester dual linkers for tunable release of dexamethasone.
Howard MD; Ponta A; Eckman A; Jay M; Bae Y
Pharm Res; 2011 Oct; 28(10):2435-46. PubMed ID: 21614636
[TBL] [Abstract][Full Text] [Related]
28. Effective doxorubicin-based nano-therapeutics for simultaneous malignant lymphoma treatment and lymphoma growth imaging.
Etrych T; Daumová L; Pokorná E; Tušková D; Lidický O; Kolářová V; Pankrác J; Šefc L; Chytil P; Klener P
J Control Release; 2018 Nov; 289():44-55. PubMed ID: 30248447
[TBL] [Abstract][Full Text] [Related]
29. Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation.
Ulbrich K; Etrych T; Chytil P; Jelínková M; Ríhová B
J Drug Target; 2004; 12(8):477-89. PubMed ID: 15621674
[TBL] [Abstract][Full Text] [Related]
30. A tumor-targeted polymer theranostics platform for positron emission tomography and fluorescence imaging.
Koziolová E; Goel S; Chytil P; Janoušková O; Barnhart TE; Cai W; Etrych T
Nanoscale; 2017 Aug; 9(30):10906-10918. PubMed ID: 28731080
[TBL] [Abstract][Full Text] [Related]
31. N-(2-Hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin for cell-specific or passive tumour targeting. Synthesis by RAFT polymerisation and physicochemical characterisation.
Chytil P; Etrych T; Kříž J; Subr V; Ulbrich K
Eur J Pharm Sci; 2010 Nov; 41(3-4):473-82. PubMed ID: 20696244
[TBL] [Abstract][Full Text] [Related]
32. Synergistic enhancement of anticancer therapeutic efficacy of HPMA copolymer doxorubicin conjugates via combination of ligand modification and stimuli-response srategies.
Li L; Zhou M; Huang Y
Int J Pharm; 2018 Jan; 536(1):450-458. PubMed ID: 29237570
[TBL] [Abstract][Full Text] [Related]
33. Improved Tumor-Specific Drug Accumulation by Polymer Therapeutics with pH-Sensitive Drug Release Overcomes Chemotherapy Resistance.
Heinrich AK; Lucas H; Schindler L; Chytil P; Etrych T; Mäder K; Mueller T
Mol Cancer Ther; 2016 May; 15(5):998-1007. PubMed ID: 26939698
[TBL] [Abstract][Full Text] [Related]
34. Tumor Stimulus-Responsive Biodegradable Diblock Copolymer Conjugates as Efficient Anti-Cancer Nanomedicines.
Šubr V; Pola R; Gao S; Islam R; Hirata T; Miyake D; Koshino K; Zhou JR; Yokomizo K; Fang J; Etrych T
J Pers Med; 2022 Apr; 12(5):. PubMed ID: 35629120
[TBL] [Abstract][Full Text] [Related]
35. Chemical modification of bradykinin-polymer conjugates for optimum delivery of nanomedicines to tumors.
Appiah E; Nakamura H; Assumang A; Etrych T; Haratake M
Nanomedicine; 2024 Apr; 57():102744. PubMed ID: 38460653
[TBL] [Abstract][Full Text] [Related]
36. Biodegradable star HPMA polymer conjugates of doxorubicin for passive tumor targeting.
Etrych T; Strohalm J; Chytil P; Černoch P; Starovoytova L; Pechar M; Ulbrich K
Eur J Pharm Sci; 2011 Apr; 42(5):527-39. PubMed ID: 21392579
[TBL] [Abstract][Full Text] [Related]
37. HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug Release.
Chytil P; Koziolová E; Etrych T; Ulbrich K
Macromol Biosci; 2018 Jan; 18(1):. PubMed ID: 28805040
[TBL] [Abstract][Full Text] [Related]
38. Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes.
Quan L; Zhang Y; Crielaard BJ; Dusad A; Lele SM; Rijcken CJF; Metselaar JM; Kostková H; Etrych T; Ulbrich K; Kiessling F; Mikuls TR; Hennink WE; Storm G; Lammers T; Wang D
ACS Nano; 2014 Jan; 8(1):458-466. PubMed ID: 24341611
[TBL] [Abstract][Full Text] [Related]
39. The structure-dependent toxicity, pharmacokinetics and anti-tumour activity of HPMA copolymer conjugates in the treatment of solid tumours and leukaemia.
Tomalova B; Sirova M; Rossmann P; Pola R; Strohalm J; Chytil P; Cerny V; Tomala J; Kabesova M; Rihova B; Ulbrich K; Etrych T; Kovar M
J Control Release; 2016 Feb; 223():1-10. PubMed ID: 26708020
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and Characterization of Nanoparticle-Based Dexamethasone-Polypeptide Conjugates as Potential Intravitreal Delivery Systems.
Zashikhina N; Gladnev S; Sharoyko V; Korzhikov-Vlakh V; Korzhikova-Vlakh E; Tennikova T
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
